openPR Logo
Press release

NGS Technology to Gain Maximum Traction in the Preimplantation Genetic Testing Market || Key Players: Natera, Inc., Rubicon Genomics, Inc., and CombiMatrix Corporation.

04-22-2019 03:14 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

NGS Technology to Gain Maximum Traction in the Preimplantation

 According to the latest report by Fact.MR, the preimplantation genetic testing market is expected to experience strong growth. The preimplantation genetic testing market is estimated to reach US$ 575.0 million revenue by 2022 end. Due to the increasing awareness of preimplantation genetic testing to avoid genetic disorders, the rise in a number of healthcare providers and healthcare institutes providing preimplantation genetic testing are the influencing factors contributing to growth of preimplantation genetic testing market.

Preimplantation genetic testing is done to find out specific genetic diseases within embryos. This testing is gaining lot of traction due to the increased risk of various diseases owing to the changing  lifestyle. Various healthcare institutes, healthcare providers, and researchers are continuously researching on the preimplantation genetic testing to find new methods to eliminate various risks involved in preimplantation genetic diagnosis.

The preimplantation genetic testing market is likely to witness steady growth over the course of the forecast period. Preimplantation genetic testing is the procedure of testing embryos to identify genetic diseases or defects before implantation. Along with implantation of healthy embryo which results in the genetically healthy baby, the preimplantation genetic testing is done to eliminate the risk of structural chromosome abnormalities, Mendelian disorders, etc.

Request Sample here:

https://www.factmr.com/connectus/sample?flag=S&rep_id=292

Among all other end users of preimplantation genetic testing, specialized clinics are expected to experience strong growth. Specialized clinics are estimated to exceed US$ 200 million revenue towards 2022 end. Meanwhile, hospitals are also expected to witness impressive growth in preimplantation genetic testing market.

Preimplantation Genetic Testing to find Largest Application in Embryo HLA Typing for Stem Cell Therapy

Embryo HLA typing for stem cell therapy is expected to show healthy growth from throughout 2017-2022. Embryo HLA typing for stem cell therapy is estimated to create an incremental opportunity exceeding US$ 70 million during 2017-2022.

 Browse Full Report on Preimplantation Genetic Testing Market with TOC-

https://www.factmr.com/report/292/preimplantation-genetic-testing-market

North America is likely to emerge as the biggest market in the global preimplantation genetic testing. North America preimplantation genetic testing market is projected to surpass US$ 200 million by the end of 2022. Increasing adoption of innovative technologies and rising awareness about preimplantation genetic testing to avoid various birth defects among babies are some of the factors fueling the market growth in the region.

Europe is expected to be the second most lucrative market for preimplantation genetic testing. Owing to the presence of various healthcare institutions and hospitals providing preimplantation genetic testing and high awareness due to the various initiatives by the government is driving the growth of preimplantation genetic testing in Europe.

 Research Methodology

Fact.MR is committed to offer unbiased and independent market research solutions to its clients. Each market report of Fact.MR is compiled after months of exhaustive research. We bank on a mix of tried-and-tested and innovative research methodologies to offer the most comprehensive and accurate information. Our main sources of research include, Primary research Secondary research Trade research Focused interviews Social media analysis

Competition Tracking

The report also profiles companies operating in the preimplantation genetic testing market, which include Agilent Technologies Inc., Abbott Laboratories, CooperSurgical Inc., Oxford Gene Technology IP, Illumina, Inc., Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Genea Limited, Natera, Inc., Rubicon Genomics, Inc., and CombiMatrix Corporation.

For More Information Raise Enquiry Here:            

https://www.factmr.com/connectus/sample?flag=AE&rep_id=292

 About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Email: sales@factmr.com

Web: https://www.factmr.com/

Read Industry News at - https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release NGS Technology to Gain Maximum Traction in the Preimplantation Genetic Testing Market || Key Players: Natera, Inc., Rubicon Genomics, Inc., and CombiMatrix Corporation. here

News-ID: 1712891 • Views:

More Releases from Fact.MR

Elevators Market to Grow at 11% CAGR, Reaching $270 Billion by 2033
Elevators Market to Grow at 11% CAGR, Reaching $270 Billion by 2033
The international elevators market (エレベーター市場) got to an evaluation of United States $ 95 billion in 2023 as well as is predicted to get to United States $ 270 billion by the end of 2033. This market is anticipated to expand at a substantial CAGR of 11% from 2023 to 2033. The elevators market stands as a crucial cog in the wheel of contemporary facilities, promoting upright mobility in significantly metropolitan
Stone Paper Market Explosive Growth CAGR of 8.0% to Reach $2,096.9 Million by 2033
Stone Paper Market Explosive Growth CAGR of 8.0% to Reach $2,096.9 Million by 20 …
The international stone paper market (ストーンペーパーマーケット) is forecasted to get to an assessment of United States $ 972.6 million by the end of 2023 and also is anticipated to expand at a CAGR of 8.0% to get to United States $ 2,096.9 million by the end of 2033. The stone paper market is experiencing considerable development possibilities driven by raising need from the product packaging as well as publishing markets. Customer
Foliar Fertilizers Market Predicts 4% CAGR, $344 Million Expansion by 2029
Foliar Fertilizers Market Predicts 4% CAGR, $344 Million Expansion by 2029
The worldwide foliar fertilizers market is forecasted to accomplish a 4% ordinary substance yearly development price (CAGR) by the verdict of the projection duration. This development is anticipated to produce an increment chance of United States$ 344 million by the end of 2029. Foliar plant foods supply an useful choice for supplying nutrients to plants as they can be straight related to the fallen leaves. This approach not just improves nutrient
E-Compass Market $11.9 Billion Discovery By 2033 | Fact.MR
E-Compass Market $11.9 Billion Discovery By 2033 | Fact.MR
In 2023, the global E-Compass Market reached a valuation of US$ 2.6 billion, and projections indicate a substantial growth trajectory, with estimates soaring to US$ 11.9 billion by 2033. 𝗚𝗲𝘁 𝗙𝗿𝗲𝗲 𝗦𝗮𝗺𝗽𝗹𝗲 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 𝗖𝗼𝗽𝘆: https://www.factmr.com/connectus/sample?flag=S&rep_id=8417 This remarkable surge in market value is attributed to the anticipated surge in worldwide electronic compass sales, expected to surge at an impressive Compound Annual Growth Rate (CAGR) of 16.5% over the coming decade. The eCompass, an electric

All 5 Releases


More Releases for Preimplantation

Preimplantation Genetic Testing Market - Forecasts to 2026
The findings reviewed by GME stated that the Global Preimplantation Genetic Testing (PGT) (PGS/PGD) Market will expand with a CAGR value of 6.2 percent from 2021 to 2026. Because of the growing incidence of genetic, inherited, and chromosomal disorders, the global PGT industry is projected to expand significantly during the projected timeline. Browse the Report @ https://www.globalmarketestimates.com/market-report/global-preimplantation-genetic-testing-pgt-market-3112 By PGD/PGS (Preimplantation Genetic Diagnosis (PGD), Preimplantation Genetic Screening (PGS)), By Type (Chromosomal Abnormalities, X-linked
Preimplantation Genetic Diagnosis Market| Key Players - Genesis Genetics, Genea …
As per the current market trends and the promising nature of the Preimplantation Genetic Diagnosis market, it can be estimated that the future holds positive outcomes. In order to provide a deep insight about the concerned market, Market Research Reports Search Engine would be publishing a resourceful analysis that will enclose knowledge about the regional market size, revenue and opportunity status. Readers will be offered the privilege to decode various
Preimplantation Genetic Testing Market is Blooming Worldwide
HTF MI recently introduced Global Preimplantation Genetic Testing Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. At present, the market is developing its presence and some of the key players from the complete study are F. Hoffmann-La Roche, Abbott Laboratories, Thermo Fisher Scientific, Natera, Illumina & Perkin Elmer etc. The market Study is segmented by key regions which
Global Preimplantation Genetic Testing Market: Growing Public-Private Investment …
The report "Preimplantation Genetic Testing Market by Products & Services (Reagents and Consumables, Software and Services and Instruments), Technology (Single-Nucleotide Polymorphism, Next-Generation Sequencing, Fluorescence in Situ Hybridization, Comparative Genomic Hybridization and Polymerase Chain Reaction), Procedure Type (Preimplantation Genetic Screening, and Preimplantation Genetic Diagnosis), Application (Single Gene Disorders, HLA Typing, Structural Chromosomal Abnormalities, X-Linked Disorders, Aneuploidy and Gender Identification), End User (Hospitals, Diagnostic Labs, and Service Providers, Research Laboratories & Academic
Preimplantation Genetic Diagnosis Market | Analysis & Trends 2023
The competitive scenario in the Asia Preimplantation Genetic Diagnostics Market is highly intense owing to the several global and local players trying their luck in the region, states Transparency Market Research (TMR) in a research report. Pertaining to the number of service providers of preimplantation genetic diagnosis market, it is a highly fragmented one in nature. The penetration of other regional players might further intensify the level of competition in
Preimplantation Genetic Diagnosis Market Studies Research Report 2023
Rising numbers of assisted reproductive procedures such as in vitro fertilization (IVF) is Asia is the most prominent factor driving the market for preimplantation genetic diagnosis. This is, in essence, the result of factors such as the delayed age of conception among Asian women, the rising rate of infertility among the population, and the significantly expanding medical tourism industry in the region. Rising disposable incomes and increased awareness regarding the